Patient Perspectives When Switching From Cosopt® (Dorzolamide-Timolol) to Azarga™ (Brinzolamide-Timolol) for Glaucoma Requiring Multiple Drug Therapy

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s33254
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Informa UK Limited

Related search

Efficiency, Safety, and Patient Preference of Switching From Dorzolamide 1%/Timolol 0.5% to Brinzolamide 1%/Timolol 0.5% While Maintaining the Prostaglandin F2α Analog

Clinical Ophthalmology
Ophthalmology
2015English

A Monocular Trial of Fixed Combination of Dorzolamide-Timolol for Primary Open-Angle Glaucoma

Journal of the Korean Glaucoma Society
2019English

Effect of Dorzolamide/Timolol Combination On the visual Field in Glaucoma

Clinical Ophthalmology
Ophthalmology
2014English

Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension

Clinical Ophthalmology
Ophthalmology
2011English

Efficacy and Safety of Switching From Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy

Open Ophthalmology Journal
Ophthalmology
2017English

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Journal of Ophthalmology
Ophthalmology
2018English

Rational Use of the Fixed Combination of Dorzolamide &Ndash; Timolol in the Management of Raised Intraocular Pressure and Glaucoma

Clinical Ophthalmology
Ophthalmology
2008English

Additive Intraocular Pressure-Lowering Effect of Dorzolamide 1%/Timolol 0.5% Fixed Combination on Prostaglandin Monotherapy in Patients With Normal Tension Glaucoma

Clinical Ophthalmology
Ophthalmology
2011English

Timolol Maleate

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy